世界の更年期治療血管運動症状市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Vasomotor Symptoms of Menopause Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5867
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、更年期治療血管運動症状のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エステトロール、フェゾリンタント、FP-101、HBN-2、その他）、用途別市場規模（病院、在宅医療、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・更年期治療血管運動症状の市場動向
・企業の競争状況、市場シェア
・更年期治療血管運動症状の種類別市場規模（エステトロール、フェゾリンタント、FP-101、HBN-2、その他）
・更年期治療血管運動症状の用途別市場規模（病院、在宅医療、クリニック）
・更年期治療血管運動症状の北米市場規模2016-2027（アメリカ、カナダ）
・更年期治療血管運動症状のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・更年期治療血管運動症状のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・更年期治療血管運動症状の中南米市場規模2016-2027（メキシコ、ブラジル）
・更年期治療血管運動症状の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen Inc.、EndoCeutics, Inc.、Euroscreen S.A.、MenoGeniX, Inc.、Mithra Pharmaceuticals S.A.、Pherin Pharmaceuticals, Inc.、Pivot Pharmaceuticals Inc、Radius Health, Inc.、TherapeuticsMD, Inc.）
・結論

Market Analysis and Insights: Global Vasomotor Symptoms of Menopause Treatment Market
The global Vasomotor Symptoms of Menopause Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vasomotor Symptoms of Menopause Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vasomotor Symptoms of Menopause Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vasomotor Symptoms of Menopause Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vasomotor Symptoms of Menopause Treatment market.

Global Vasomotor Symptoms of Menopause Treatment Scope and Market Size
Vasomotor Symptoms of Menopause Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vasomotor Symptoms of Menopause Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Estetrol
Fezolinetant
FP-101
HBN-2
Others

Segment by Application
Hospital
Homecare
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc.
EndoCeutics, Inc.
Euroscreen S.A.
MenoGeniX, Inc.
Mithra Pharmaceuticals S.A.
Pherin Pharmaceuticals, Inc.
Pivot Pharmaceuticals Inc
Radius Health, Inc.
TherapeuticsMD, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Estetrol
1.2.3 Fezolinetant
1.2.4 FP-101
1.2.5 HBN-2
1.2.6 Others
1.3 Market by Application
1.3.1 Global Vasomotor Symptoms of Menopause Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Vasomotor Symptoms of Menopause Treatment Market Perspective (2016-2027)
2.2 Vasomotor Symptoms of Menopause Treatment Growth Trends by Regions
2.2.1 Vasomotor Symptoms of Menopause Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vasomotor Symptoms of Menopause Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Vasomotor Symptoms of Menopause Treatment Industry Dynamic
2.3.1 Vasomotor Symptoms of Menopause Treatment Market Trends
2.3.2 Vasomotor Symptoms of Menopause Treatment Market Drivers
2.3.3 Vasomotor Symptoms of Menopause Treatment Market Challenges
2.3.4 Vasomotor Symptoms of Menopause Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue
3.1.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue (2016-2021)
3.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Vasomotor Symptoms of Menopause Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vasomotor Symptoms of Menopause Treatment Revenue
3.4 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio
3.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vasomotor Symptoms of Menopause Treatment Revenue in 2020
3.5 Vasomotor Symptoms of Menopause Treatment Key Players Head office and Area Served
3.6 Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
3.7 Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Vasomotor Symptoms of Menopause Treatment Breakdown Data by Type
4.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Type (2016-2021)
4.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2022-2027)

5 Vasomotor Symptoms of Menopause Treatment Breakdown Data by Application
5.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Application (2016-2021)
5.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
6.2 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type
6.2.1 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
6.2.2 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
6.2.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
6.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application
6.3.1 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
6.3.2 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
6.3.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
6.4 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country
6.4.1 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021)
6.4.2 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
7.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type
7.2.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
7.2.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
7.2.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
7.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application
7.3.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
7.3.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
7.3.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
7.4 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country
7.4.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021)
7.4.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
8.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type
8.2.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application
8.3.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region
8.4.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
9.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type
9.2.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
9.3 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application
9.3.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
9.4 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country
9.4.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size (2016-2027)
10.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type
10.2.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application
10.3.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country
10.4.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.1.4 Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.1.5 Amgen Inc. Recent Development
11.2 EndoCeutics, Inc.
11.2.1 EndoCeutics, Inc. Company Details
11.2.2 EndoCeutics, Inc. Business Overview
11.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.2.4 EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.2.5 EndoCeutics, Inc. Recent Development
11.3 Euroscreen S.A.
11.3.1 Euroscreen S.A. Company Details
11.3.2 Euroscreen S.A. Business Overview
11.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Introduction
11.3.4 Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.3.5 Euroscreen S.A. Recent Development
11.4 MenoGeniX, Inc.
11.4.1 MenoGeniX, Inc. Company Details
11.4.2 MenoGeniX, Inc. Business Overview
11.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.4.4 MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.4.5 MenoGeniX, Inc. Recent Development
11.5 Mithra Pharmaceuticals S.A.
11.5.1 Mithra Pharmaceuticals S.A. Company Details
11.5.2 Mithra Pharmaceuticals S.A. Business Overview
11.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Introduction
11.5.4 Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.5.5 Mithra Pharmaceuticals S.A. Recent Development
11.6 Pherin Pharmaceuticals, Inc.
11.6.1 Pherin Pharmaceuticals, Inc. Company Details
11.6.2 Pherin Pharmaceuticals, Inc. Business Overview
11.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.6.4 Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.6.5 Pherin Pharmaceuticals, Inc. Recent Development
11.7 Pivot Pharmaceuticals Inc
11.7.1 Pivot Pharmaceuticals Inc Company Details
11.7.2 Pivot Pharmaceuticals Inc Business Overview
11.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Introduction
11.7.4 Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.7.5 Pivot Pharmaceuticals Inc Recent Development
11.8 Radius Health, Inc.
11.8.1 Radius Health, Inc. Company Details
11.8.2 Radius Health, Inc. Business Overview
11.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.8.4 Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.8.5 Radius Health, Inc. Recent Development
11.9 TherapeuticsMD, Inc.
11.9.1 TherapeuticsMD, Inc. Company Details
11.9.2 TherapeuticsMD, Inc. Business Overview
11.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
11.9.4 TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
11.9.5 TherapeuticsMD, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Estetrol
Table 3. Key Players of Fezolinetant
Table 4. Key Players of FP-101
Table 5. Key Players of HBN-2
Table 6. Key Players of Others
Table 7. Global Vasomotor Symptoms of Menopause Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Vasomotor Symptoms of Menopause Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Vasomotor Symptoms of Menopause Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Vasomotor Symptoms of Menopause Treatment Market Share by Regions (2016-2021)
Table 11. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Vasomotor Symptoms of Menopause Treatment Market Share by Regions (2022-2027)
Table 13. Vasomotor Symptoms of Menopause Treatment Market Trends
Table 14. Vasomotor Symptoms of Menopause Treatment Market Drivers
Table 15. Vasomotor Symptoms of Menopause Treatment Market Challenges
Table 16. Vasomotor Symptoms of Menopause Treatment Market Restraints
Table 17. Global Vasomotor Symptoms of Menopause Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Vasomotor Symptoms of Menopause Treatment Market Share by Players (2016-2021)
Table 19. Global Top Vasomotor Symptoms of Menopause Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasomotor Symptoms of Menopause Treatment as of 2020)
Table 20. Ranking of Global Top Vasomotor Symptoms of Menopause Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Vasomotor Symptoms of Menopause Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
Table 24. Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Vasomotor Symptoms of Menopause Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Inc. Company Details
Table 65. Amgen Inc. Business Overview
Table 66. Amgen Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 67. Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 68. Amgen Inc. Recent Development
Table 69. EndoCeutics, Inc. Company Details
Table 70. EndoCeutics, Inc. Business Overview
Table 71. EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 72. EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 73. EndoCeutics, Inc. Recent Development
Table 74. Euroscreen S.A. Company Details
Table 75. Euroscreen S.A. Business Overview
Table 76. Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Product
Table 77. Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 78. Euroscreen S.A. Recent Development
Table 79. MenoGeniX, Inc. Company Details
Table 80. MenoGeniX, Inc. Business Overview
Table 81. MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 82. MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 83. MenoGeniX, Inc. Recent Development
Table 84. Mithra Pharmaceuticals S.A. Company Details
Table 85. Mithra Pharmaceuticals S.A. Business Overview
Table 86. Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Product
Table 87. Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 88. Mithra Pharmaceuticals S.A. Recent Development
Table 89. Pherin Pharmaceuticals, Inc. Company Details
Table 90. Pherin Pharmaceuticals, Inc. Business Overview
Table 91. Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 92. Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 93. Pherin Pharmaceuticals, Inc. Recent Development
Table 94. Pivot Pharmaceuticals Inc Company Details
Table 95. Pivot Pharmaceuticals Inc Business Overview
Table 96. Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product
Table 97. Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 98. Pivot Pharmaceuticals Inc Recent Development
Table 99. Radius Health, Inc. Company Details
Table 100. Radius Health, Inc. Business Overview
Table 101. Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 102. Radius Health, Inc. Recent Development
Table 103. TherapeuticsMD, Inc. Company Details
Table 104. TherapeuticsMD, Inc. Business Overview
Table 105. TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Product
Table 106. TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2016-2021) & (US$ Million)
Table 107. TherapeuticsMD, Inc. Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vasomotor Symptoms of Menopause Treatment Market Share by Type: 2020 VS 2027
Figure 2. Estetrol Features
Figure 3. Fezolinetant Features
Figure 4. FP-101 Features
Figure 5. HBN-2 Features
Figure 6. Others Features
Figure 7. Global Vasomotor Symptoms of Menopause Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Homecare Case Studies
Figure 10. Clinic Case Studies
Figure 11. Vasomotor Symptoms of Menopause Treatment Report Years Considered
Figure 12. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Vasomotor Symptoms of Menopause Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Vasomotor Symptoms of Menopause Treatment Market Share by Regions (2022-2027)
Figure 16. Global Vasomotor Symptoms of Menopause Treatment Market Share by Players in 2020
Figure 17. Global Top Vasomotor Symptoms of Menopause Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasomotor Symptoms of Menopause Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Vasomotor Symptoms of Menopause Treatment Revenue in 2020
Figure 19. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 23. North America Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 24. North America Vasomotor Symptoms of Menopause Treatment Market Share by Country (2016-2027)
Figure 25. United States Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 29. Europe Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 30. Europe Vasomotor Symptoms of Menopause Treatment Market Share by Country (2016-2027)
Figure 31. Germany Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Share by Region (2016-2027)
Figure 41. China Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Vasomotor Symptoms of Menopause Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 61. EndoCeutics, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 62. Euroscreen S.A. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 63. MenoGeniX, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 64. Mithra Pharmaceuticals S.A. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 65. Pherin Pharmaceuticals, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 66. Pivot Pharmaceuticals Inc Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 67. Radius Health, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 68. TherapeuticsMD, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の更年期障害治療市場規模・現状・予測（2021年-2027年）

Global Menopause Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3702 2021年4月 95Pages
QYResearch社発行の本調査資料では、更年期障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、非ホルモン療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の脂質障害治療市場規模・現状・予測（2021年-2027年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3432 2021年4月 98Pages
QYResearch社発行の本調査資料では、脂質障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他）、用途別市場規模（病院、クリニック、その他）、主要...

世界のジフテリア治療市場規模・現状・予測（2021年-2027年）

Global Diphtheria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1902 2021年4月 95Pages
QYResearch社発行の本調査資料では、ジフテリア治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（破傷風免疫グロブリン、破傷風トキソイド、破傷風-ジフテリア、ジフテリアトキソイド、百日咳）、用途別市場規模（抗毒素、抗生物質、その他）、主...

世界のナルコレプシー治療市場規模・現状・予測（2021年-2027年）

Global Narcolepsy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4022 2021年4月 94Pages
QYResearch社発行の本調査資料では、ナルコレプシー治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発...

世界の水疱性類天疱瘡治療市場規模・現状・予測（2021年-2027年）

Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1030 2021年4月 97Pages
QYResearch社発行の本調査資料では、水疱性類天疱瘡治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）、用途別市場規模（病院薬局、小売薬局、通信販売薬局）、主要地域別市場規模（北米、アメ...

世界の裂肛治療市場規模・現状・予測（2021年-2027年）

Global Anal Fissure Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0309 2021年4月 91Pages
QYResearch社発行の本調査資料では、裂肛治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所ニトログリセリン、カルシウムチャネル遮断薬、便軟化剤、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリ...

世界の軟骨肉腫治療市場規模・現状・予測（2021年-2027年）

Global Chondrosarcoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1305 2021年4月 99Pages
QYResearch社発行の本調査資料では、軟骨肉腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、化学療法、放射線療法）、用途別市場規模（病院、専門クリニック、がん治療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の多発性内分泌腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Endocrine Neoplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3952 2021年4月 97Pages
QYResearch社発行の本調査資料では、多発性内分泌腺腫症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界のエストラジオール経皮システム市場規模・現状・予測（2021年-2027年）

Global Estradiol Transdermal System Market Size, Status and Forecast 2021-2027
QYR2104Z2252 2021年4月 90Pages
QYResearch社発行の本調査資料では、エストラジオール経皮システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（1日0.025mg、1日0.0375mg、1日0.05mg、1日0.075mg、1日0.1mg）、用途別市場規模（ほてり、閉...

世界のハンセン病治療市場規模・現状・予測（2021年-2027年）

Global Leprosy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3400 2021年4月 91Pages
QYResearch社発行の本調査資料では、ハンセン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（スルホン、フェナジン誘導体、抗管状薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の更年期障害治療市場規模・現状・予測（2021年-2027年） Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children. Menopause typically occurs between 49 and 52 years of age. Medical professionals often define menopause as having occurred when a woman h…
世界の網膜芽細胞腫治療市場規模・現状・予測（2021年-2027年） Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. Market Analysis and Insights: Global Retinoblastoma Treatment Market The global Retinoblastoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during…
世界の光線療法治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Phototherapy Treatment Market The global Phototherapy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…
世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年） Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in seri…
世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年） Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in seri…